233 related articles for article (PubMed ID: 11886434)
21. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis.
Stirpe F; Derenzini M; Barbieri L; Farabegoli F; Brown AN; Knowles PP; Thorpe PE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):259-71. PubMed ID: 2889289
[TBL] [Abstract][Full Text] [Related]
22. Characterization of translational inhibitors from Phytolacca americana. Amino-terminal sequence determination and antibody-inhibitor conjugates.
Bjorn MJ; Larrick J; Piatak M; Wilson KJ
Biochim Biophys Acta; 1984 Oct; 790(2):154-63. PubMed ID: 6091760
[TBL] [Abstract][Full Text] [Related]
23. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography.
Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ
J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254
[TBL] [Abstract][Full Text] [Related]
24. In vivo and in vitro uptake of an anti-CD30/saporin immunotoxin by rat liver parenchymal and nonparenchymal cells.
Battelli MG; Buonamici L; Bolognesi A; Stirpe F
Hepatology; 1994 Oct; 20(4 Pt 1):940-7. PubMed ID: 7927236
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
[TBL] [Abstract][Full Text] [Related]
26. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin.
Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F
Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell LA; Agrawal A; Ross DA; Muraszko KM
Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
[TBL] [Abstract][Full Text] [Related]
28. Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodies.
Sforzini S; de Totero D; Gaggero A; Ippoliti R; Glennie MJ; Canevari S; Stein H; Ferrini S
Br J Haematol; 1998 Sep; 102(4):1061-8. PubMed ID: 9734659
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
Ishiguro K; Ho PT; Sartorelli AC
Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
[TBL] [Abstract][Full Text] [Related]
30. Immunotoxins to the HER-2 oncogene product: functional and ultrastructural analysis of their cytotoxic activity.
Di Lazzaro C; Digiesi G; Tecce R; Lotti LV; Torrisi MR; Natali PG
Cancer Immunol Immunother; 1994 Nov; 39(5):318-24. PubMed ID: 7987863
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cytotoxic activity of saporin anti-gp185/HER-2 immunotoxins.
Tecce R; Digiesi G; Savarese A; Trizio D; Natali PG
Int J Cancer; 1993 Aug; 55(1):122-7. PubMed ID: 8102128
[TBL] [Abstract][Full Text] [Related]
32. Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings.
Wrenn CC; Picklo MJ; Lappi DA; Robertson D; Wiley RG
Brain Res; 1996 Nov; 740(1-2):175-84. PubMed ID: 8973812
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE
Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899
[TBL] [Abstract][Full Text] [Related]
34. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
35. Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin.
Urch CE; George AJ; Stevenson GT; Bolognesi A; Stirpe F; Weller R; Glennie MJ
Int J Cancer; 1991 Apr; 47(6):909-15. PubMed ID: 2010234
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
Miller K; Wilder PJ; Rizzino A
Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
[TBL] [Abstract][Full Text] [Related]
37. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
Tetzke TA; Caton MC; Maher PA; Parandoosh Z
Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
[TBL] [Abstract][Full Text] [Related]
39. A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins.
Heisler I; Keller J; Tauber R; Sutherland M; Fuchs H
Int J Cancer; 2003 Jan; 103(2):277-82. PubMed ID: 12455044
[TBL] [Abstract][Full Text] [Related]
40. Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation.
Tazzari PL; Bolognesi A; de Totero D; Falini B; Lemoli RM; Soria MR; Pileri S; Gobbi M; Stein H; Flenghi L
Br J Haematol; 1992 Jun; 81(2):203-11. PubMed ID: 1322690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
